Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes by Hugo Barcenilla, Linda Åkerman, Mikael Pihl, Johnny Ludvigsson, Johnny Ludvigsson, Rosaura Casas

Get full text

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes by Beatriz Tavira, Hugo Barcenilla, Jeannette Wahlberg, Peter Achenbach, Johnny Ludvigsson, Rosaura Casas

Get full text

Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes by Hugo Barcenilla, Mikael Pihl, Jeanette Wahlberg, Jeanette Wahlberg, Johnny Ludvigsson, Johnny Ludvigsson, Rosaura Casas

Get full text

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype by Sara Puente-Marin, Fabrícia Dietrich, Peter Achenbach, Peter Achenbach, Hugo Barcenilla, Johnny Ludvigsson, Johnny Ludvigsson, Rosaura Casas

Get full text

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets by Louise Magnusson, Louise Magnusson, Hugo Barcenilla, Mikael Pihl, Sophie Bensing, Daniel Espes, Daniel Espes, Per-Ola Carlsson, Per-Ola Carlsson, Rosaura Casas

Get full text